During the past decade, Erlanger Hospital Pharmacy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Erlanger Hospital Pharmacy" are "Arteriovenous Fistula" (1 trials) and "Arteriovenous Graft" (1 trials). Many other conditions were trialed in "Erlanger Hospital Pharmacy" in a lesser frequency.

Most popular intervention types in "Erlanger Hospital Pharmacy" are "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Participating Site's standard practice" (2 trials) and "SRM003" (2 trials). Other intervention names were less common.

The vast majority of trials in "Erlanger Hospital Pharmacy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Erlanger Hospital Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Erlanger Hospital Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Erlanger Hospital Pharmacy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".